Mary Bond

Senior Director of Clinical Pharmacology Mary Bond, MS, MBA has more than 20 years of industry experience in early clinical development, leading numerous clinical pharmacology programs for both small and large molecules at SmithKline Beecham, GlaxoSmithKline, Cephalon, and Teva. She has been responsible for the design and oversight of more than 100 early phase studies and has contributed to more than 12 INDs/CTAs and 15 marketing applications both in the U.S. and abroad.